Case report: Conversion therapy for advanced intrahepatic cholangiocarcinoma using PD-1 inhibitor plus S-1 and nab-paclitaxel

Intrahepatic cholangiocarcinoma (iCCA) is a highly malignant hepatobiliary tumor with a high rate of advanced disease at initial presentation. Conversion into resectable iCCA is important for improving the prognosis. Immunotherapy-based regimens are being increasingly used for treating advanced iCCA...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaocheng, Jiang, Zhiyang, Wu, Yongjuan, Gong, Wei, Liao, Xiaofeng, Li, Xiaogang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366243/
https://www.ncbi.nlm.nih.gov/pubmed/35965578
http://dx.doi.org/10.3389/fonc.2022.935817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366243/
https://www.ncbi.nlm.nih.gov/pubmed/35965578
http://dx.doi.org/10.3389/fonc.2022.935817

Ejemplares similares